SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-159926
Filing Date
2024-06-12
Accepted
2024-06-12 16:01:35
Documents
16
Period of Report
2024-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d55926d8k.htm   iXBRL 8-K 42488
2 EX-4.1 d55926dex41.htm EX-4.1 155162
3 EX-10.1 d55926dex101.htm EX-10.1 32530
  Complete submission text file 0001193125-24-159926.txt   448136

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20240611.xsd EX-101.SCH 4471
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20240611_def.xml EX-101.DEF 13889
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20240611_lab.xml EX-101.LAB 23245
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20240611_pre.xml EX-101.PRE 14858
20 EXTRACTED XBRL INSTANCE DOCUMENT d55926d8k_htm.xml XML 6193
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 241038354
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)